These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

503 related articles for article (PubMed ID: 23179775)

  • 1. Therapy of adrenal insufficiency: an update.
    Falorni A; Minarelli V; Morelli S
    Endocrine; 2013 Jun; 43(3):514-28. PubMed ID: 23179775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improving outcomes in patients with adrenal insufficiency: a review of current and future treatments.
    Johannsson G; Skrtic S; Lennernäs H; Quinkler M; Stewart PM
    Curr Med Res Opin; 2014 Sep; 30(9):1833-47. PubMed ID: 24849526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Secondary adrenal insufficiency: from the physiopathology to the possible role of modified-release hydrocortisone treatment.
    Paragliola RM; Corsello SM
    Minerva Endocrinol; 2018 Jun; 43(2):183-197. PubMed ID: 28750490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Naloxone-induced activation of the hypothalamic-pituitary-adrenal axis in suspected central adrenal insufficiency.
    Blevins LS; Dobs AS; Wand GS
    Am J Med Sci; 1994 Sep; 308(3):167-70. PubMed ID: 8074133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulsatile Subcutaneous Hydrocortisone Replacement in Primary Adrenal Insufficiency.
    Simunkova K; Løvås K; Methlie P; Jovanovic N; Bifulco E; Bronstad I; Lightman SL; Husebye ES; Oksnes M
    Horm Metab Res; 2023 Jul; 55(7):471-478. PubMed ID: 37172949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Replacement therapy of oral hydrocortisone in adrenal insufficiency: the influence of gastrointestinal factors.
    Lennernäs H; Skrtic S; Johannsson G
    Expert Opin Drug Metab Toxicol; 2008 Jun; 4(6):749-58. PubMed ID: 18611115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of adrenal insufficiency in different clinical settings.
    Hahner S; Allolio B
    Expert Opin Pharmacother; 2005 Nov; 6(14):2407-17. PubMed ID: 16259572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circadian hydrocortisone infusions in patients with adrenal insufficiency and congenital adrenal hyperplasia.
    Merza Z; Rostami-Hodjegan A; Memmott A; Doane A; Ibbotson V; Newell-Price J; Tucker GT; Ross RJ
    Clin Endocrinol (Oxf); 2006 Jul; 65(1):45-50. PubMed ID: 16817818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic strategies in adrenal insufficiency.
    Oelkers W; Diederich S; Bähr V
    Ann Endocrinol (Paris); 2001 Apr; 62(2):212-6. PubMed ID: 11353897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors impacting on the action of glucocorticoids in patients receiving glucocorticoid therapy.
    Dineen R; Stewart PM; Sherlock M
    Clin Endocrinol (Oxf); 2019 Jan; 90(1):3-14. PubMed ID: 30120786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of short-term nocturnal cortisol replacement on cognitive function and quality of life in patients with primary or secondary adrenal insufficiency: a pilot study.
    Harbeck B; Kropp P; Mönig H
    Appl Psychophysiol Biofeedback; 2009 Jun; 34(2):113-9. PubMed ID: 19387826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolated corticotrophin deficiency.
    Andrioli M; Pecori Giraldi F; Cavagnini F
    Pituitary; 2006; 9(4):289-95. PubMed ID: 17077949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoglycaemia in adrenal insufficiency.
    Lee SC; Baranowski ES; Sakremath R; Saraff V; Mohamed Z
    Front Endocrinol (Lausanne); 2023; 14():1198519. PubMed ID: 38053731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adrenal insufficiency.
    Kumar R; Wassif WS
    J Clin Pathol; 2022 Jul; 75(7):435-442. PubMed ID: 35534201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Adrenal insufficiency and treatment with glucocorticosteroid].
    Lindholm J
    Ugeskr Laeger; 2016 Mar; 178(12):V10150788. PubMed ID: 27032433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Addison's disease, primary adrenal insufficiency in adults].
    Krikke M; ten Wolde M; Smit N
    Ned Tijdschr Geneeskd; 2013; 157(37):A6078. PubMed ID: 24020621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [CME: Adrenal Insufficiency].
    Fischli S
    Praxis (Bern 1994); 2018 Jun; 107(13):717-725. PubMed ID: 29921185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of once-daily, modified-release hydrocortisone versus standard glucocorticoid therapy on metabolism and innate immunity in patients with adrenal insufficiency (DREAM): a single-blind, randomised controlled trial.
    Isidori AM; Venneri MA; Graziadio C; Simeoli C; Fiore D; Hasenmajer V; Sbardella E; Gianfrilli D; Pozza C; Pasqualetti P; Morrone S; Santoni A; Naro F; Colao A; Pivonello R; Lenzi A
    Lancet Diabetes Endocrinol; 2018 Mar; 6(3):173-185. PubMed ID: 29229498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. European Adrenal Insufficiency Registry (EU-AIR): a comparative observational study of glucocorticoid replacement therapy.
    Ekman B; Fitts D; Marelli C; Murray RD; Quinkler M; Zelissen PM
    BMC Endocr Disord; 2014 May; 14():40. PubMed ID: 24884782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated hair cortisol concentrations in children with adrenal insufficiency on hydrocortisone replacement therapy.
    Noppe G; van Rossum EF; Vliegenthart J; Koper JW; van den Akker EL
    Clin Endocrinol (Oxf); 2014 Dec; 81(6):820-5. PubMed ID: 25039686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.